Related Experiment Video
Updated: May 19, 2026
08:04
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Ocular actions of platelet-activating factor: clinical implications
Eirini Nitoda1, Marilita M Moschos, Clio P Mavragani
1National & Kapodistrian University of Athens, Medical School, Department of Ophthalmology, 121, Marathonodromou Street, Marousi, 15125, Athens, Greece.
Expert Opinion on Therapeutic Targets
|August 29, 2012
Summary
Platelet-activating factor (PAF) plays a key role in inflammatory eye diseases, contributing to conditions like uveitis and retinal vascular issues. Understanding PAF
Area of Science:
- Ophthalmology
- Immunology
- Pathophysiology
Background:
- Platelet-activating factor (PAF) is a potent inflammatory mediator.
- PAF is implicated in various chronic inflammatory disorders and allergic reactions.
Purpose of the Study:
- To review the evidence for PAF's role in inflammatory ocular diseases.
- To explore PAF's involvement in conditions affecting vision.
Main Methods:
- Literature review of studies on PAF and ocular inflammation.
- Analysis of PAF's function in ocular surface protection and disease pathogenesis.
Main Results:
- PAF contributes to ocular surface inflammation, potentially causing allergic reactions, corneal neovascularization, and haze.
- PAF activity is associated with uveitis pathogenesis.
- PAF is linked to hypoxia and blood-retina barrier breakdown in retinal diseases like AMD and diabetic retinopathy.
Conclusions:
- Understanding PAF's role in vision-threatening diseases is crucial for improved clinical treatments.
- Further research into PAF antagonists may offer therapeutic benefits for ocular inflammatory conditions.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...